Small Cap Feast
Small Cap Feast – 20 November 2019
Set Menu AIM:
Total number of AIM Companies (Incl Susp):
Total number of AIM Companies trading: *
* As at
Set Menu NEX Growth:
Total number of NEX Growth Market Companies (Incl Susp): *
Total number of NEX Growth Market Companies trading: *
* As at
Set Menu Standard List:
Total number of Standard List Companies (Incl Susp): *
Total number of Standard List Companies trading: *
* As at
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
Dish of the Day:
Off the Menu:
What’s Cooking in the IPO Kitchen?
What’s cooking in the IPO kitchen?
The Pebble Group, a provider of products, services and technology to the global promotional products industry, announces its intention to seek admission of its shares to trading on the AIM market of the London Stock Exchange, which is expected to take place in early December 2019.The Group delivered revenue of £99.8m in the year ended 31 December 2018.No mention of bottom line and a suggestion that funds raised would provide an exit to private equity shareholders and the repayment of debt. Offer TBA.
Longboat Energy raising £10m. Expected admission November 2019. The company has been established by the former management team of Faroe Petroleum to create a new full-cycle North Sea oil and gas company .The strategy to achieve this will initially be through the acquisition of assets where the management team can add value through subsurface and operational improvements, follow-up deal opportunities and near-field exploration; and by value creation through the drill bit.
Sapo PLC – an investment vehicle under the NEX Exchange Rules, seeks to invest in the developing market for rural broadband in the United Kingdom. Due 2 Dec
Main Mkt Standard
Taseko Mines – North American focused copper producer and developer, seeking a London Listing. No capital raise. Due 22 Dec
SDIC Power – “potential intention to float”. Proposed GDR listing. Leading power generation company in China, with a diversified portfolio of projects across hydropower, coal-fired power, wind power and solar power. Offer TBA
Falcon Oil & Gas (FOG.L) 13.6p £124m
Preliminary drilling data from the vertical section of the Kyalla 117 N2-1 appraisal well confirms:
The continuation of the regionally pervasive Kyalla Fm between the Beetaloo W-1 and Amungee NW-1H wells.
Elevated gas show with relatively high C3, C4 and C5 components were observed across the carbonaceous shales.
The JV is now preparing to drill the horizontal section within the Kyalla formation.
Horizontal drilling will commence following the final evaluation of the vertical well results.
Once completed, the horizontal section will be fracture stimulated, and production tested.
The JV has prepared for continued operations during the wet season.
Property Franchise Group (TPFG.L) 156.65p £39.64m
Trading during H2 to date has remained strong, and management are confident that the Group remains in line to achieve market expectations for the full year. “We are pleased to report that the Group has set a new record for lettings revenue at a franchisee level in the trading month of October 2019. Our franchisees reported lettings income of £5.96m. Significantly, this was achieved despite the loss of tenant fee income, following the ban on charging tenant fees having come into effect in England & Wales on 1 June 2019. Tenant fees had previously represented 16% of our franchisees’ lettings revenue in these jurisdictions.”
“We had previously advised investors that it could take until the end of 2020 to fully mitigate the lost revenue from the ban, however management is now confident that the objective of full mitigation will be attained by June 2020, one year after the introduction of the ban.”
Diurnal (DNL.L) 34p £29.38m
Positive headline results from the Company’s DITEST™ (native oral testosterone formulation) Phase I proof-of-concept clinical trial. Confirms the positive findings in the Company’s successful in vivo pre-clinical studies, evaluated the pharmacokinetics, safety and tolerability of DITEST™ in the target patient group of 24 adult men with primary or secondary hypogonadism. “”Currently available topical formulations of native testosterone have significant compliance and potential safety issues while, to date, attempts to create oral preparations of modified testosterone have resulted in products with considerable pharmacokinetic variability and a requirement to be taken with a high-fat meal.”
“I am strongly encouraged by these study results, which demonstrate that the DITEST™ formulation has the potential to address these needs.”
Finsbury Foods (FIF.L) 84p £109.5m
“The momentum from the second half of the previous financial year has been maintained, and we continue to achieve strong growth across the core business. Sales for the first four months of the new financial year grew by 6.4% to £101.5m, as a result of a strong retail and foodservice performance in the UK, as well as new business wins and continued innovation across the Group.
“Whilst the wider macroeconomic and political environment remains challenging in the UK, the Group is in its strongest position in recent years, and the Board is confident in achieving market expectations in FY20.”
Breedon Group (BREE.L) 62.35p £1.1bn
Trading update. Breedon delivered a strong performance in the 10 months to 31 October 2019, with increased revenues, improved underlying EBIT and continuing robust cash generation, including a 10-month contribution from the former Lagan Group (“Lagan”), acquired in April 2018.
These results were achieved against the backdrop of a flat construction market in Great Britain. Group revenues grew by eight per cent to approximately £800 m. Assuming no materially adverse weather conditions for the remainder of the year, the Group’s Underlying EBIT for the full year is expected to be in line with current market expectations .
Goldstone Resources (GRL.L) 1.65p £4.1m
The Ghanaian Ministry of Lands and Natural Resources (“MLNR”) has approved the recommendation for the grant of a 10 year mining lease on the Akrokeri and Homase Licences, for the Homase South Pit and land for the plant and process operation. The Company now awaits issue of the Lease by MLNR.
The Lease represents an important step in the Company’s goal of bring the Akrokeri-Homase Gold Project into production. The Homase South Pit is the first of the three pits along the Homase Trend which GoldStone will bring into production as detailed in the Definitive Economic Plan announced on 27 June 2019.
Advanced Oncotherapy (AVO.L) 39.5p £94m
The developer of next-generation proton therapy systems for cancer treatment, is pleased to announce an equity fundraise of approximately £2.7 m which will contribute to the funding for progressing verification and validation activity in order to obtain regulatory approval of its first LIGHT system. Priced at 25p a 33% discount to yesterday’s close.
Infrastrata (INFA.L) 0.305p £4.6m
The AIM quoted company focused on strategic infrastructure projects, announced an offer of new ordinary shares in the Company to shareholders that are Qualifying Participants and an offer of Ordinary Shares on the PrimaryBid platform to raise collectively gross proceeds of up to £1 m.
This is subsequent to a recent £6m placing at of £6m at 0.3p. The Board considers it important to allow existing Shareholders to participate on the same terms as investors who participated under the Placing . The aggregate gross proceeds of the Fundraise are limited to £1 m but may be increased, at the Board’s sole discretion, to up to £2 m.
Mercia Asset Management (MERC.L) 31.4p £89.5m
Update on direct portfolio company, nDreams Limited (37.1% fully diluted) New contract for the VR at home market and follows the announcement of nDreams’ latest title, Phantom: Covert Ops, which the company is developing in partnership with Oculus Studios. The reception for Phantom: Covert Ops, which was on show at this year’s E3 Expo in Los Angeles, has been outstanding and resulted in the team winning E3’s Game Critics Award for ‘Best VR/AR Game’, as well as six other award wins including Game Informer’s ‘Best VR Game’.
European Metals (EMH.L) 22.25p £32.4m
Conditional agreement with CEZ Group , one of Central and Eastern Europe’s largest power utilities, regarding a potential strategic partnership and significant investment into the Cinovec Project. If concluded, the agreement will see, subject to the successful completion of due diligence, shareholder, and other approvals, CEZ become a 51% shareholder in Geomet s.r.o. (“Geomet”), the Company’s Czech subsidiary and holder of the rights over the Project, for consideration of approximately €34.06 m.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email email@example.com with “unsubscribe me”.